opipramol

This page covers all opipramol drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sigma non-opioid intracellular receptor 1.

Targets

Sigma non-opioid intracellular receptor 1

Phase 3 pipeline (1)

• Opramidol · Neuroscience
  Opipramol works by binding to the sigma non-opioid intracellular receptor 1, which helps to regulate mood and emotional responses.

Patent intelligence

• opipramol patent landscape — aggregated cliff calendar, attackable patents, originator estates